Home/Filings/4/0001415889-25-010440
4//SEC Filing

Cho James 4

Accession 0001415889-25-010440

CIK 0001656634other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 8:59 PM ET

Size

17.1 KB

Accession

0001415889-25-010440

Insider Transaction Report

Form 4
Period: 2025-04-04
Cho James
SVP, CHIEF ACCOUNTING OFFICER
Transactions
  • Other

    Stock Option (Right to Buy)

    2025-04-0465,4000 total
    Exercise: $0.96Exp: 2034-05-02Common Stock (65,400 underlying)
  • Other

    Stock Option (Right to Buy)

    2025-04-0426,3000 total
    Exercise: $5.46Exp: 2022-01-30Common Stock (26,300 underlying)
  • Other

    Stock Option (Right to Buy)

    2025-04-0440,0000 total
    Exercise: $7.14Exp: 2029-11-12Common Stock (40,000 underlying)
  • Other

    Common Stock

    2025-04-04155,1230 total
  • Other

    Stock Option (Right to Buy)

    2025-04-04109,0000 total
    Exercise: $2.46Exp: 2034-01-31Common Stock (109,000 underlying)
  • Other

    Stock Option (Right to Buy)

    2025-04-0425,0000 total
    Exercise: $13.87Exp: 2031-03-07Common Stock (25,000 underlying)
Footnotes (6)
  • [F1]Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value.
  • [F2]Includes 122,515 unvested restricted stock units.
  • [F3]The option vests as to 1/24th of the total grant monthly beginning February 1, 2024 until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.
  • [F4]The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on July 31, 2025, subject to the continued service of the Reporting Person on each vesting date.
  • [F5]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from January 31, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
  • [F6]The options are fully vested.

Issuer

Gritstone bio, Inc.

CIK 0001656634

Entity typeother

Related Parties

1
  • filerCIK 0001891475

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 8:59 PM ET
Size
17.1 KB